First-line bevacizumab combined with reduced dose interferon- 2a is active in patients with metastatic renal cell carcinoma

Published 2008 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
First-line bevacizumab combined with reduced dose interferon- 2a is active in patients with metastatic renal cell carcinoma
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 19, Issue 8, Pages 1470-1476
Publisher
Oxford University Press (OUP)
Online
2008-04-13
DOI
10.1093/annonc/mdn161

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.